Literature DB >> 2973182

Metabolism of 14C-thymoxamine in rat and man.

P Duchene1, C Bernouillet, M Bromet-Petit, J Mosser, C Feniou, D Gaudin, H Virelizier.   

Abstract

1. After oral administration of 14C-thymoxamine to rat and man the total 14C excreted in urine and faeces was determined. 2. Six metabolites were isolated from the excret of man and rat by chemical extraction and identified by g.l.c.-mass spectral analyses. 3. Two other metabolites, highly polar and resistant to enzymic hydrolysis, were isolated by extraction on XAD2 resin and h.p.l.c. analysis. These two metabolites were identified by n.m.r. and by mass spectrometry in the fast atomic bombardment mode. 4. These two major metabolites of thymoxamine in man and rat have been identified and characterized as the sulphate conjugates of desacetyl-thymoxamine and N-monodesmethyl-desacetyl-thymoxamine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973182     DOI: 10.3109/00498258809167515

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

1.  Pharmacokinetics of moxisylyte in healthy volunteers after intracavernous injection of increasing doses.

Authors:  F Bressolle; P Costa; R Rouzier-Panis; C Marquer
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  Pharmacokinetics of thymoxamine in rabbits after ophthalmic and intravenous administration.

Authors:  I Aldana; E González-Peñas; D Fos; L Bruseghini; A Esteras; N Ceppi Monti; V Gianesello
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

3.  Pharmacokinetics of a prodrug thymoxamine: dose-dependence of the metabolite ratio in healthy subjects.

Authors:  C Marquer; J H Trouvin; J Y Lacolle; C Dupont; C Jacquot
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.